FDA approved psychedelics

In 2026, the medical community is witnessing a historic paradigm shift as FDA-approved psychedelics like Psilocybin and MDMA transition from controversial substances to frontline clinical treatments for treatment-resistant mental health conditions. The Silent Revolution in Mental Health For decades, psychiatry has relied on the same classes of SSRIs and SNRIs, which often manage symptoms rather … Read more